ANIP compared with KNSA: revenue, margins and what each company keeps, and the suppliers and customers both name

ANIPANI Pharmaceuticals Inc

Mkt capRevenueRevenue

KNSAKiniksa Pharmaceuticals International, plc

Mkt capRevenueRevenue

Compare

ANIPANI Pharmaceuticals Inc

KNSAKiniksa Pharmaceuticals International, plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ANIP 33

—Three customersunlistedcustomer

—One domestic supplierunlistedsupplier

WMTWalmartcustomer

CVSCVScustomer

29 more · ANIP chain ›

Shared 0

No shared counterparties.

Only KNSA 10

REGNRegeneronsupplier

BIIBBiogen MAsupplier

—Samsungunlistedsupplier

—Beth Israel Deaconess Medical Center, Inc. ("BIDMC")

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

6 more · KNSA chain ›

ANIPANI Pharmaceuticals Inc

71.69▲+1.45%

Mkt cap$1.6BRevenue$266MQ2 FY26Revenue$883MFY25

KNSAKiniksa Pharmaceuticals International, plc

93.42▲+2.88%

Regular sessionNov 3 '26

Mkt cap$7.1BRevenue$286MQ3 FY26Revenue$678MFY25

Compare

Regular sessionNov 3 '26

ANIPANI Pharmaceuticals Inc

KNSAKiniksa Pharmaceuticals International, plc

71.69▲+1.45%

Price

93.42▲+2.88%

$1.6B

Mkt cap

$7.1B

Q2 FY26$266M

Revenue

$286MQ3 FY26

FY25$883M

Revenue

$678MFY25

ANIP71.69▲+1.45%vsKNSA93.42▲+2.88%Regular sessionNov 3 '26